Published in Medicine and Law Weekly, October 20th, 2006
Study 1: Head and neck cancer patients with severe co-morbidities, unfit to receive concomitant chemotherapy, could be treated a novel strategy that combines carbogen breathing with radical radiotherapy.
In a recent article published in the journal Clinical Oncology, scientists in Switzerland assessed "the feasibility of carbogen breathing combined with radical radiotherapy in patients with advanced head and neck cancer who are unfit to receive concomitant chemotherapy. Twenty patients (median age 66 years) with advanced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly